Latest IBD Registry data submission and site numbers
As we approach the end of the year, the Registry team would like to thank all the IBD teams who have now joined the project for all their hard work. We’ve reached an important milestone in November with 20 sites now having submitted data, giving a total of 17,328 records. More records will be uploaded in December as we now have 44 teams who have completed their registration with NHS Digital. If you have data you’d like to upload and need any help at all please contact Mark at [email protected]
Altogether, 176 IBD teams from across the UK have registered to participate, and there are 78 sites ‘live’ with a system for data capture, using a variety of different data entry methods (e.g. web tool, patient management system, local system etc). If you’re in one of the teams that haven’t yet registered please contact [email protected] to find out more about joining in.
Important information about the transition from audit to IBD Registry
As you know, the UK IBD audit team at the Royal College of Physicians (RCP) have delivered their final report, and data collection to support audit and quality improvement in IBD is now moving to the IBD Registry. Clinical teams can participate using their own choice of data entry system to suit local needs – including some existing local systems.
The RCP Biologics web tool will be closing in mid-January. All sites who want to retain their biologics audit data should make arrangements for this to be exported. You will receive an email from the IBD audit project team at the RCP explaining how to do this. Those users who want to import this data into the IBD Registry Web Tool should contact the IBD Registry team by emailing Mark at [email protected]. The RCP biologics audit data will no longer be accessible to sites after the RCP web tool closes in mid-January.
As part of the transition, we’d really encourage teams to attend 10 years of the UK IBD audit: framing the future at the Royal College of Physicians in London on Friday 3 February 2017. The meeting will celebrate the successes of 10 years of the IBD audit programme and outline opportunities for continued quality improvement using the Registry. There will be time for networking and best practice sharing. Click here to book your free ticket
The first 30 people to register will be also eligible for a £50 reduction against their travel arrangements if booked by 15th December. If you would like to take advantage of this early booking offer, please select the General admission – Early bird £50 voucher ticket (details on claiming this offer are provided on the ticket).
Funding for 2017/18 and letter from the BSG to NHS Trust CEOs in England
A letter was recently sent to IBD Clinical Leads at hospitals in England explaining that with the loss of NHS England funding for the IBD Biologics Audit and Quality Improvement Programme and its transfer to the Registry from February 2017, the BSG would be seeking an annual subscription payment from NHS Trusts to cover part of the cost of running the programme. The subscription has been set at £2,500 per annum, in line with other national audits. Users of the Web Tool will be asked to pay an additional £1,000 per annum. We will shortly be writing to Trust CEOs reminding them of the importance of the Biologics Audit in terms of quality and safety, and seeking their commitment to subscribe in the coming year. A copy of the letter to Clinical Leads is available on request from [email protected]
What to do next
If you’ve registered to join the IBD Registry you will have information about what you need to do to participate. If you haven’t already done so, please register to be part of the programme using the form here.
If you’d like more information on any aspect of joining the IBD Registry or entering data please contact [email protected]
Find out more about…
We’re looking for a motivated and organised Operations Manager to lead on management of our ongoing service operations and our new projects stream, as well as the information governance and general compliance that underpins both of these. Our ongoing service...read more
The IBD Registry is inviting IBD clinical teams across the UK to participate in a post-marketing safety study of patients using biosimilar Zessly (infliximab). This study is facilitated by the Registry on behalf of Sandoz Ltd, the manufacturer of Zessly. The purpose...read more
The IBD Registry is delighted a presentation prepared by the Registry’s Analytics Hub at the University of Liverpool featured in the British Society of Gastroenterology Annual Meeting in Glasgow. The Audit of biological therapy for IBD - Shawihdi et al Poster BSG 2019...read more
The IBD Registry says the launch of the new IBD Standards, the first for six years, at the BSG Annual meeting in Glasgow today, Thursday, 20th June, will provide a catalyst to drive quality in inflammatory bowel disease (IBD). The IBD Standards, produced by IBD UK, an...read more
Continuing its mission to improve the care that people with IBD receive, the Royal College of Physicians is offering IBD teams an opportunity to participate in a new quality improvement collaborative, consisting of three 1-day learning sessions and supported action...read more